October 22, 2014 11:17 PM ET

Biotechnology

Company Overview of Vasogen Inc.

Company Overview

As of October 22, 2009, Vasogen Inc. was acquired by IntelliPharmaCeutics Ltd., in a reverse merger transaction. Vasogen Inc. focuses on the research and commercial development of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neuro-inflammatory disorders. It is not advancing the development of its products and is focused is on exploring strategic options that may include a sale of the company, a merger, an acquisition, or other strategic alternative. The company was founded 1980 and is headquartered in Mississauga, Canada.

4 Robert Speck Parkway

15th Floor

Mississauga, ON L4Z 1S1

Canada

Founded in 1980

1 Employees

Phone:

905-402-9925

Fax:

905-847-6270

Key Executives for Vasogen Inc.

Vasogen Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
BC Research Institute for Children's & Women's Health Americas
ImTec Therapeutics Ltd Americas
Milestone Pharmaceuticals Inc. Americas
DNA Labeling Americas
Telogene Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vasogen Inc., please visit www.vasogen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.